Figure 2From: Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancerPatient self-assessment of changes in quality of life over time (a) Functional scales, (b) Symptom scales. *Significant difference with baseline (Wilcoxon signed rank test, p <0.05); * (in red) Statistically significant and clinically relevant difference (>10 points).Back to article page